Cargando…
Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia
OBJECTIVE: The aim of this work was to evaluate the cost-effectiveness of evolocumab in addition to standard statin therapy with or without ezetimibe in the treatment of patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) with levels of LDL-C above 100 mg/dL. METHOD: A th...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ORIGINAL RESEARCH ARTICLE
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616188/ https://www.ncbi.nlm.nih.gov/pubmed/36627880 http://dx.doi.org/10.33393/grhta.2021.2255 |